Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | +4.95% | +3.22% | -17.16% |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Jan. 11 | Acorda Therapeutics, Inc. to Regain Global Commercialization Rights to FAMPYRA by January 2025 | CI |
- Stock
- Equities
- Stock Acorda Therapeutics, Inc. - Nasdaq
- News Acorda Therapeutics, Inc.